ClinicalTrials.Veeva

Menu

Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics (EC0991002-E)

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Frailty
Sarcopenia

Study type

Observational

Funder types

Other

Identifiers

NCT02073370
EC0991002-E (Registry Identifier)
201010021R

Details and patient eligibility

About

Sarcopenia related mobility dysfunction was a preventable presentation in transitional variation of frailty. However, the definition, associated risk factors, clinical course and outcome of sarcopenia in Taiwanese older adults are still under-clarified and need for further study.

Enrollment

350 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • functional decline in recent one year
  • cognitive impairment
  • depressive symptom
  • mobility impairment
  • fall in recent one year
  • eating or feeding problems
  • weight loss
  • co-morbid conditions≧5
  • tracking by different physician ≧3 in recent half year
  • poly-pharmacy≧8 in recent 3 months
  • hospitalization ≧1 in recent one year
  • emergency visits≧2 in recent one year
  • aged ≧ 80.

Exclusion criteria

  • non-ambulatory (bed-ridden) patients
  • long-term residents at nursing homes
  • patients with a life expectancy shorter than six months
  • impairment in vision, hearing, or communicative ability, making convenience of clinical evaluation during the study period impossible.

Trial design

350 participants in 1 patient group

health subjects; outpatients aged over 65
Description:
The research subjects will be culled from outpatients aged over 65 at NTUH; 1000 Taiwanese subjects aged 20-40 equally divided in both genders will be recruited in order to establish the norm of Taiwanese's skeletal muscle index.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems